21 May 2019
Which interventional strategy for diabetes mellitus patients? Understanding the challenges of PCI in everyday clinical practice
Sponsored by Alvimedica
Chairpersons:
G. Sardella, M. Valgimigli
Panellists:
R. Byrne, R. Romaguera
Summary
Consult this session to learn more about PCI performances with DES in diabetes mellitus patients, and discover all about the latest technological advancements provided by the innovative amphilimus-eluting polymer-free DES (Cre8 EVO).
Learning Objectives
- To review PCI performances with DES in diabetes mellitus patients
- To learn the latest technological advancements provided by the innovative amphilimus-eluting polymer-free DES (Cre8 EVO) in diabetes mellitus patients
- To understand how to bridge the gap between PCI guidelines in diabetes mellitus patients and everyday clinical practice